(Q38259780)

1 September 2017

1 reference

title

Autism spectrum disorder: an omics perspective (English)

1 reference

1 September 2017

main subject

autism spectrum disorder

0 references

autism

0 references

author name string

Alisa G Woods

1

1 reference

1 September 2017

Kelly L Wormwood

2

1 reference

1 September 2017

Armand G Ngounou Wetie

3

1 reference

1 September 2017

Roshanak Aslebagh

4

1 reference

1 September 2017

Bernard S Crimmins

5

1 reference

1 September 2017

Thomas M Holsen

6

1 reference

1 September 2017

Costel C Darie

7

1 reference

1 September 2017

publication date

6 November 2014

1 reference

Proteomics - Clinical Applications

1 September 2017

published in

1 reference

1 September 2017

volume

9

1 reference

1 September 2017

issue

1-2

1 reference

1 September 2017

page(s)

159-168

1 reference

Treating clients with Asperger's syndrome and autism

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Autism Spectrum Disorder: Defining Dimensions and Subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

AutismKB: an evidence-based knowledgebase of autism genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

The conundrums of understanding genetic risks for autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Genetic aspects of autism spectrum disorders: insights from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Autism as a strongly genetic disorder: evidence from a British twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

A broader phenotype of autism: the clinical spectrum in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Molecular genetics of autism spectrum disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Genetic and brain structure anomalies in autism spectrum disorders. Towards an understanding of the aetiopathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Disruptive CHD8 mutations define a subtype of autism early in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Convergence of genes and cellular pathways dysregulated in autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Working up autism: the practical role of medical genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Autism spectrum disorder in the genetics clinic: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

A research strategy to discover the environmental causes of autism and neurodevelopmental disabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Tipping the balance of autism risk: potential mechanisms linking pesticides and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Environmental chemicals in pregnant women in the United States: NHANES 2003-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Phosphorus flame retardants: properties, production, environmental occurrence, toxicity and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Detection of organophosphate flame retardants in furniture foam and U.S. house dust

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Analytical developments and preliminary assessment of human exposure to organophosphate flame retardants from indoor dust

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

The role of neurotrophic factors in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Autism: an emerging 'neuroimmune disorder' in search of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Potential biomarkers in psychiatry: focus on the cholesterol system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Autism from 2 to 9 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

How useful are screening instruments for toddlers to predict outcome at age 4? General development, language skills, and symptom severity in children with a false positive screen for autism spectrum disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Proteomic research in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

A pilot proteomic study of protein markers in autism spectrum disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Paired measurements of paraoxonase 1 and serum amyloid A as useful disease markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Human PON1, a biomarker of risk of disease and exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

PON1 and neurodevelopment in children from the CHAMACOS study exposed to organophosphate pesticides in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

A novel blood-based biomarker for detection of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Comparative Human Salivary and Plasma Proteomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Mass spectrometry for the study of autism and neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Two-dimensional gel electrophoresis: recent advances in sample preparation, detection and quantitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Sex-specific serum biomarker patterns in adults with Asperger's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Biological sex affects the neurobiology of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Identification of an age-dependent biomarker signature in children and adolescents with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Mass spectrometric analysis of post-translational modifications (PTMs) and protein-protein interactions (PPIs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Protein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Identifying transient protein-protein interactions in EphB2 signaling by blue native PAGE and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Investigation of stable and transient protein-protein interactions: Past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Neurochemical correlates of autistic disorder: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Serotonin uptake stimulating peptide found in plasma of normal individuals and in some autistic urines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Altered vascular phenotype in autism: correlation with oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

The behavioral phenotype of FMR1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Fragile X syndrome and targeted treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Early identification of autism in fragile X syndrome: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Behavioral phenotype of fragile X syndrome in adolescence and adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Advances in the treatment of fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

The challenges of clinical trials in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Outcome measures for clinical trials in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Mass spectrometric evidence that proteolytic processing of rainbow trout egg vitelline envelope proteins takes place on the egg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Proteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Proteomic analysis reveals CCT is a target of Fragile X mental retardation protein regulation in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Protein expression profiling of the drosophila fragile X mutant brain reveals up-regulation of monoamine synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

The Drosophila fragile X-related gene regulates axoneme differentiation during spermatogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Molecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Autism: the role of cholesterol in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Smith-Lemli-Opitz syndrome and autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Cognitive and behavioral aspects of Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Abnormalities of cholesterol metabolism in autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Potential of sterol analysis by liquid chromatography-tandem mass spectrometry for the prenatal diagnosis of Smith-Lemli-Opitz syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Analysis by liquid chromatography-mass spectrometry of sterols and oxysterols in brain of the newborn Dhcr7(Δ3-5/T93M) mouse: a model of Smith-Lemli-Opitz syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Direct analysis of sterols from dried plasma/blood spots by an atmospheric pressure thermal desorption chemical ionization mass spectrometry (APTDCI-MS) method for a rapid screening of Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Nanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Ion-current-based proteomic profiling of the retina in a rat model of Smith-Lemli-Opitz syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Retinal degeneration in a rat model of Smith-Lemli-Opitz Syndrome: thinking beyond cholesterol deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Autism biomarkers: challenges, pitfalls and possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Identifying New Persistent and Bioaccumulative Organics Among Chemicals in Commerce

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

Sterol profiles in plasma and erythrocyte membranes in patients with Smith-Lemli-Opitz syndrome: a six-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400116

21 January 2018

Identifiers

DOI

10.1002/PRCA.201400116

1 reference

1 September 2017

1 reference